scholarly article | Q13442814 |
P356 | DOI | 10.1161/STROKEAHA.107.484360 |
P8608 | Fatcat ID | release_ta5xt4tmzfhxpokhcn4z32iify |
P698 | PubMed publication ID | 17569871 |
P2093 | author name string | R Loch Macdonald | |
Jocelyn Tolentino | |||
Axel J Rosengart | |||
Kim E Schultheiss | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
P304 | page(s) | 2315-2321 | |
P577 | publication date | 2007-06-14 | |
P1433 | published in | Stroke Journal | Q7624282 |
P1476 | title | Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage | |
P478 | volume | 38 |
Q38687560 | "Clip first" policy in management of intracranial MCA aneurysms: Single-centre experience with a systematic review of literature. |
Q55019304 | A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage. |
Q38976777 | A computational simulation of the effect of hemodilution on oxygen transport in middle cerebral artery vasospasm |
Q33830250 | A novel technique for morphometric quantification of subarachnoid hemorrhage-induced microglia activation |
Q35738018 | A possible new focus for stroke treatment - migrating stem cells |
Q44757992 | A predictive model of outcomes during cerebral aneurysm coiling |
Q39879998 | Analysis of Factors That Influence Long-Term Independent Living for Elderly Subarachnoid Hemorrhage Patients. |
Q35829188 | Aneurismal subarachnoid hemorrhage: who remains for surgical treatment in the post-ISAT era? |
Q40093151 | Aneurysmal subarachnoid hemorrhage prognostic decision-making algorithm using classification and regression tree analysis |
Q39067874 | Anticoagulation Therapy in Patients Suffering from Aneurysmal Subarachnoid Hemorrhage: Influence on Functional Outcome-a Single-Center Series and Multivariate Analysis |
Q45749797 | Aspirin and aneurysmal subarachnoid hemorrhage |
Q26752317 | Association between S100B Levels and Long-Term Outcome after Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Pooled Analysis |
Q92572935 | Association between blood pressure variability and the short-term outcome in patients with acute spontaneous subarachnoid hemorrhage |
Q89608067 | Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults |
Q48615552 | Automatic quantification of subarachnoid hemorrhage on noncontrast CT. |
Q33752053 | Biomarkers and acute brain injuries: interest and limits |
Q53076594 | CT Angiography for Differentiation between Intracerebral and Intra-Sylvian Hematoma in Patients with Ruptured Middle Cerebral Artery Aneurysms |
Q41039125 | Cerebral Taurine Levels are Associated with Brain Edema and Delayed Cerebral Infarction in Patients with Aneurysmal Subarachnoid Hemorrhage. |
Q41022794 | Cerebral microcirculatory failure after subarachnoid hemorrhage is reversed by hyaluronidase |
Q91568404 | Cerebral vasospasm following spontaneous subarachnoid hemorrhage: Angiographic pattern and its impact on the clinical course |
Q35789432 | Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage |
Q48942808 | Cerebrospinal fluid high mobility group box 1 is associated with neuronal death in subarachnoid hemorrhage. |
Q40898286 | Clinical features of subarachnoid hemorrhage in patients with positive cancer history |
Q30419248 | Clinical outcome prediction in aneurysmal subarachnoid hemorrhage using Bayesian neural networks with fuzzy logic inferences |
Q91030425 | Cognitive Impairment, Functional Outcome, and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage |
Q44994328 | Cognitive, physical, and psychological status after intracranial aneurysm rupture: a cross-sectional study of a Stockholm case series 1996 to 1999. |
Q93574315 | Commentary |
Q89952244 | Comparison of Minimally Invasive and Pterional Craniotomies for Ruptured Anterior Circulation Aneurysms: A Propensity Score Matched Analysis |
Q36262082 | Computed tomography angiography spot sign predicts intraprocedural aneurysm rupture in subarachnoid hemorrhage |
Q38207521 | Control of blood pressure in hypertensive neurological emergencies |
Q37611673 | Correlation of clinical outcome with pressure-, oxygen-, and flow-related indices of cerebrovascular reactivity in patients following aneurysmal SAH. |
Q36195900 | Cyclophilin A in Ruptured Intracranial Aneurysm: A Prognostic Biomarker |
Q49214349 | D-dimer may predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage: a retrospective study |
Q38169976 | Delayed neurological deterioration after subarachnoid haemorrhage |
Q53731099 | Determinants of poor outcome after aneurysmal subarachnoid hemorrhage when both clipping and coiling are available: Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) in Japan. |
Q64236467 | Development and external validation of new nomograms by adding ECG changes (ST depression or tall T wave) and age to conventional scoring systems to improve the predictive capacity in patients with subarachnoid haemorrhage: a retrospective, observati |
Q90685636 | Discrepancy in neurologic outcomes following aneurysmal subarachnoid hemorrhage as a function of socioeconomic class |
Q48711274 | Distal posterior inferior cerebellar artery aneurysms: clinical features and outcome of 80 patients. |
Q46081531 | Early ambulation produces favorable outcome and nondemential state in aneurysmal subarachnoid hemorrhage patients older than 70 years of age. |
Q43966801 | Early predictors of prolonged stay in a critical care unit following aneurysmal subarachnoid hemorrhage |
Q40154437 | Effect of High-Dose Simvastatin on Cerebral Blood Flow and Static Autoregulation in Subarachnoid Hemorrhage |
Q37834294 | Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis |
Q50994825 | Effects of Clot Removal by Meticulous Irrigation and Continuous Low-Dose Intravenous Nicardipine on Symptomatic Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage Treated by Clipping. |
Q35097918 | Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage |
Q47987416 | Elevated glycated hemoglobin level and hyperglycemia after aneurysmal subarachnoid hemorrhage |
Q36476201 | Elevated high-sensitive troponin T on admission is an indicator of poor long-term outcome in patients with subarachnoid haemorrhage: a prospective observational study |
Q33659746 | Emergency neurological care of strokes and bleeds |
Q35869464 | Endovascular treatment for ruptured vertebral artery dissecting aneurysms: results from Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2. |
Q43496074 | Epileptiform activity in neurocritical care patients. |
Q50079500 | Factors associated with clinical and radiological status on admission in patients with aneurysmal subarachnoid hemorrhage. |
Q48521695 | Feasibility of Real-Time Angiographic Perfusion Imaging in the Treatment of Cerebral Vasospasm. |
Q38454324 | Fever burden and functional recovery after subarachnoid hemorrhage |
Q38960313 | Functional Outcome After Poor-Grade Subarachnoid Hemorrhage: A Single-Center Study and Systematic Literature Review. |
Q40540835 | Health Care Costs of Spontaneous Aneurysmal Subarachnoid Hemorrhage for Rehabilitation, Home Care, and In-Hospital Treatment for the First Year |
Q47926401 | High-Dose Nadroparin Following Endovascular Aneurysm Treatment Benefits Outcome After Aneurysmal Subarachnoid Hemorrhage |
Q37772395 | Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome |
Q42683412 | Idiopathic subarachnoid hemorrhage: a multicentre series of 220 patients |
Q58771168 | Impact of Comorbidities and Smoking on the Outcome in Aneurysmal Subarachnoid Hemorrhage |
Q92979767 | Impact of Dysnatremia and Dyskalemia on Prognosis in Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Study |
Q36518408 | Impact of electrolyte imbalances on the outcome of aneurysmal subarachnoid hemorrhage: A prospective study. |
Q82037499 | Implications of early versus late bilateral pulmonary infiltrates in patients with aneurysmal subarachnoid hemorrhage |
Q91982509 | Interleukin-6 Levels in Cerebrospinal Fluid and Plasma in Patients with Severe Spontaneous Subarachnoid Hemorrhage |
Q35692105 | Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms |
Q36922766 | International Subarachnoid Aneurysm Trial - ISAT part II: study protocol for a randomized controlled trial |
Q26825331 | Intracranial hemorrhage |
Q93088127 | Intrathecal Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage: Evidence From Randomized Controlled Trials and Cohort Studies |
Q37837083 | Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. |
Q51102181 | Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial. |
Q45011676 | Is a sylvian fissure hematoma caused by leaking vessels? |
Q53364610 | Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid hemorrhage? |
Q37782561 | Locally-administered Intrathecal Thrombolytics Following Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis |
Q44367669 | Long-term outcome in surviving patients after clipping of intracranial aneurysms |
Q38798046 | Loss of Consciousness at Onset of Aneurysmal Subarachnoid Hemorrhage is Associated with Functional Outcomes in Good-Grade Patients |
Q38634279 | MRI Detection of Cerebral Infarction in Subarachnoid Hemorrhage. |
Q46240492 | Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage |
Q38438688 | Methamphetamine use is an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage |
Q35045868 | Monitoring of brain oxygenation in surgery of ruptured middle cerebral artery aneurysms |
Q34907295 | Monitoring of brain tissue oxygenation in surgery of middle cerebral artery incidental aneurysms. |
Q43835249 | Monitoring with the Somanetics INVOS 5100C after aneurysmal subarachnoid hemorrhage |
Q37732612 | Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage |
Q45945258 | Multivariable and Bayesian Network Analysis of Outcome Predictors in Acute Aneurysmal Subarachnoid Hemorrhage: Review of a Pure Surgical Series in the Postinternational Subarachnoid Aneurysm Trial Era. |
Q37026953 | Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage. |
Q55024490 | Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage. |
Q41072097 | Neurosurgeon academic impact is associated with clinical outcomes after clipping of ruptured intracranial aneurysms |
Q82693923 | Nimodipine--oral or intravenous? No--subarachnoid |
Q83174657 | Paediatric intracranial empyema: differences according to age |
Q40390942 | Perioperative fever and outcome in surgical patients with aneurysmal subarachnoid hemorrhage |
Q35773165 | Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy |
Q64094972 | Poor-Grade Aneurysmal Subarachnoid Hemorrhage: Risk Factors Affecting Clinical Outcomes in Intracranial Aneurysm Patients in a Multi-Center Study |
Q33774744 | Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT) |
Q89282395 | Prediction of outcome after aneurysmal subarachnoid haemorrhage using data from patient admission |
Q53078605 | Predictive Factors of Fever After Aneurysmal Subarachnoid Hemorrhage and Its Impact on Delayed Cerebral Ischemia and Clinical Outcomes. |
Q35102818 | Predictor's of Mortality in Patients with Aneurysmal Subarachnoid Haemorrhage and Reebleding |
Q48458436 | Predictors and outcome of acute symptomatic cerebral infarctions following aneurysmal subarachnoid hemorrhage |
Q34327425 | Predictors and outcomes of shunt-dependent hydrocephalus in patients with aneurysmal sub-arachnoid hemorrhage. |
Q84448652 | Prevalence, timing, risk factors, and mechanisms of anterior cerebral artery infarctions following subarachnoid hemorrhage |
Q42908270 | Preventing Vasospasm Improves Outcome After Aneurysmal Subarachnoid Hemorrhage: Rationale and Design of CONSCIOUS-2 and CONSCIOUS-3 Trials |
Q37408151 | Procedure-related Complication Rate for the Endovascular Treatment of Aneurysmal Subarachnoid Hemorrhage under Local Anesthesia. |
Q35959209 | Prognosis of ultra-early microsurgery combined with extraventricular drainage in patients with poor-grade aneurysms. |
Q52991389 | Prognostic Value of the Amount of Bleeding After Aneurysmal Subarachnoid Hemorrhage: A Quantitative Volumetric Study. |
Q44274962 | Prognostic prediction of patients with poor-grade aneurysmal subarachnoid hemorrhage and additional intracerebral hemorrhage |
Q91964348 | Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH) |
Q49178482 | Protective effects of atorvastatin on cerebral vessel autoregulation in an experimental rabbit model of subarachnoid hemorrhage |
Q36216786 | Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subara |
Q40184914 | Real-Time, In Vivo Monitoring, and Quantitative Assessment of Intra-Arterial Vasospasm Therapy |
Q104472027 | Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies |
Q93056677 | Reduced Admission Serum Fibrinogen Levels Predict 6-Month Mortality of Poor-Grade Aneurysmal Subarachnoid Hemorrhage |
Q41004576 | Reduced Quality of Life in Patients with Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Prospective Longitudinal Study |
Q48298670 | Regional variations in brain oxygenation during temporary clipping in aneurysm surgery. |
Q47998525 | Relation of gray-white matter ratio with long-term cognitive functions and quality of life in patients with mild to moderate aneurysmal subarachnoid hemorrhage: a prospective observational study. |
Q36060738 | Relationship between angiographic vasospasm and regional hypoperfusion in aneurysmal subarachnoid hemorrhage. |
Q39103850 | Relationship between angiographic vasospasm, cerebral blood flow, and cerebral infarction after subarachnoid hemorrhage. |
Q51857829 | Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. |
Q89205255 | Relationship between systolic blood pressures measured in emergency department and outcomes in patients with subarachnoid hemorrhage |
Q37400544 | Resuscitation and critical care of poor-grade subarachnoid hemorrhage |
Q55317081 | Risk Factors for Unfavorable Outcome in Aneurysmal Subarachnoid Hemorrhage Revisited; Odds and Ends. |
Q90109391 | Risk Management of Aneurysmal Subarachnoid Hemorrhage by Age and Treatment Method from a Nationwide Database in Japan |
Q50993001 | Risk factors for 1-year mortality in patients with nontraumatic intracranial hemorrhage requiring intensive care. |
Q82694375 | Risk factors for three phases of 12-month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage |
Q40217980 | Robust effects of genetic background on responses to subarachnoid hemorrhage in mice |
Q90231108 | Role of Apolipoprotein E Genotypes in Aneurysmal Subarachnoid Hemorrhage: Susceptibility, Complications, and Prognosis |
Q47267614 | Rupture of a non-traumatic anterior communicating artery aneurysm: Does location of aneurysm associate with functional independence following post-acute in-patient neurorehabilitation? |
Q41680464 | Short term outcomes following clipping and coiling of ruptured intracranial aneurysms: does some of the benefit of coiling stem from less procedural impact on deranged physiology at presentation? |
Q89926162 | Soluble vascular endothelial-cadherin in CSF after subarachnoid hemorrhage |
Q52121177 | Spontaneous subarachnoid haemorrhage. |
Q39663927 | Statins and anti-inflammatory therapies for subarachnoid hemorrhage. |
Q37634417 | Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis |
Q45029428 | Subarachnoid haemorrhage WFNS grade V: is maximal treatment worthwhile? |
Q87380218 | Subarachnoid hemorrhage and intracerebral hematoma caused by aneurysms of the anterior circulation: influence of hematoma localization on outcome |
Q38186664 | Subarachnoid hemorrhage: a review of experimental studies on the microcirculation and the neurovascular unit |
Q38577070 | Systematic review of clinical prediction tools and prognostic factors in aneurysmal subarachnoid hemorrhage |
Q40432542 | Temperature rhythm in aneurysmal subarachnoid hemorrhage |
Q89729227 | Temporal Muscle as an Indicator of Sarcopenia is Independently Associated with Hunt and Kosnik Grade on Admission and the Modified Rankin Scale Score at 6 Months of Patients with Subarachnoid Hemorrhage Treated by Endovascular Coiling |
Q38959930 | The Barrow Neurological Institute Scale Revisited: Predictive Capabilities for Cerebral Infarction and Clinical Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage |
Q55042825 | The Factors Associated with Outcomes in Surgically Managed Ruptured Cerebral Aneurysm. |
Q56957521 | The Hijdra scale has significant prognostic value for the functional outcome of Fisher grade 3 patients with subarachnoid hemorrhage |
Q50139647 | The Link between Cerebrovascular Hemodynamics and Rehabilitation Outcomes after Aneurysmal Subarachnoid Hemorrhage. |
Q99414986 | The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies |
Q104130542 | The Woven EndoBridge (WEB) versus Conventional Coiling for Treatment of Patients with Aneurysmal Subarachnoid Haemorrhage: Propensity Score-Matched Analysis of Clinical and Angiographic Outcome Data |
Q64086314 | The association of neutrophil-to-lymphocyte ratio and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: possible involvement of cerebral blood perfusion |
Q33780528 | The clinical profile, management, and overall outcome of aneurysmal subarachnoid hemorrhage at the neurosurgical unit of a tertiary care center in India |
Q37894424 | The evolving role of hemodilution in treatment of cerebral vasospasm: a historical perspective. |
Q48026041 | The impact of temporary artery occlusion during intracranial aneurysm surgery on long-term clinical outcome: part I. Patients with subarachnoid hemorrhage |
Q92331892 | The important role of connexin 43 in subarachnoid hemorrhage-induced cerebral vasospasm |
Q38213375 | The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. |
Q37208973 | The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage. |
Q36377542 | The relationship between subarachnoid hemorrhage volume and development of cerebral vasospasm |
Q57488615 | The use of SAPS 3, SOFA, and Glasgow Coma Scale to predict mortality in patients with subarachnoid hemorrhage: A retrospective cohort study |
Q48853023 | The value of the Charlson Co-morbidity Index in aneurysmal subarachnoid haemorrhage |
Q33382252 | Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm |
Q24240010 | Tirilazad for aneurysmal subarachnoid haemorrhage |
Q40037364 | Treatment of ruptured middle cerebral aneurysms associated with intracerebral hematomas |
Q50778478 | Ultra-early (within 24 hours) aneurysm treatment after subarachnoid hemorrhage. |
Q40496281 | Ultra-early Detection of Microcirculatory Injury as Predictor of Developing Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage |
Q36825822 | Ultra-early microsurgical treatment within 24 h of SAH improves prognosis of poor-grade aneurysm combined with intracerebral hematoma |
Q99590157 | Unfavorable Outcome after Good Grade Aneurysmal Subarachnoid Hemorrhage: An Exploratory Analysis |
Q89390882 | Unfavorable Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage WFNS Grade I |
Q55362801 | Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage. |
Q36291849 | Value of Perfusion CT, Transcranial Doppler Sonography, and Neurological Examination to Detect Delayed Vasospasm after Aneurysmal Subarachnoid Hemorrhage |
Q40133547 | Value of transcranial Doppler, perfusion-CT and neurological evaluation to forecast secondary ischemia after aneurysmal SAH. |
Q37344487 | Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study. |
Q39103863 | Vasospasm: my first 25 years-what worked? what didn't? what next? |
Q52982863 | Volume perfusion CT imaging of cerebral vasospasm: diagnostic performance of different perfusion maps. |
Q34619162 | What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases. |
Q43698455 | Withdrawal of technological life support following subarachnoid hemorrhage |